Skip to main content

Mesoridazine

  • Reference work entry
  • First Online:
  • 1 Accesses

Generic Name

Mesoridazine

Brand Name

Serentil, Lidanil

Class

Antipsychotic (conventional)

Proposed Mechanism(s) of Action

Dopamine 2 receptor blocker.

Indication

Schizophrenia.

Off-Label Use

Uncommon.

Side Effects

Serious

QT prolongation, agranulocytosis, seizures, neuroleptic malignant syndrome, ventricular arrhythmia, and sudden death.

Common

Akathisia, neuroleptic-induced deficit syndrome, extrapyramidal symptoms, priapism, galactorrhea, amenorrhea, pigmentary retinopathy, sexual dysfunction, dry mouth, blurred vision, and weight gain.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   1,099.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References and Readings

  • Physicians’ Desk Reference. (62nd ed.). (2007). Montvale: Thomson PDR.

    Google Scholar 

  • Stahl, S. M. (2007). Essential psychopharmacology: The prescriber’s guide (2nd ed.). New York: Cambridge University Press.

    Google Scholar 

Additional Information

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Efrain Antonio Gonzalez .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Akins, C., Gonzalez, E.A. (2018). Mesoridazine. In: Kreutzer, J.S., DeLuca, J., Caplan, B. (eds) Encyclopedia of Clinical Neuropsychology. Springer, Cham. https://doi.org/10.1007/978-3-319-57111-9_1674

Download citation

Publish with us

Policies and ethics